David T Howton's Net Worth

$50.6 Million

Estimate Recalculated Jul 17, 2024 03:15PM EST

Who is David T Howton?

David T Howton has an estimated net worth of $50.6 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, Sarepta Therapeutics, Inc., and Solid Biosciences Inc..

SEC CIK

David T Howton's CIK is 0001529297

Past Insider Trading and Trends

2019 was David T Howton's most active year for acquiring shares with 14 total transactions. David T Howton's most active month to acquire stocks was the month of January. 2019 was David T Howton's most active year for disposing of shares, totalling 20 transactions. David T Howton's most active month to dispose stocks was the month of October. 2019 saw David T Howton paying a total of $2,693,497.15 for 184,091 shares, this is the most they've acquired in one year. In 2019 David T Howton cashed out on 275,763 shares for a total of $17,659,797.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $418.46

SVP & Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+109.65%
10.17K
$0.01
$101.66
19.44K
Feb 2
Form 4
-3.42%
-328.00
$44.29
-$14,527.12
9.27K
Scheduled
Sep 1
Form 3
—
0
—
—
0
No matching records found

Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $126.28

EVP, General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$98.32
-$15,254,390.90
31.87K
Scheduled
Jun 22
Form 4
+26.62%
6.7K
—
—
31.87K
Feb 28
Form 4
—
0
$73.49
-$8,113,561.05
25.17K
Scheduled
Dec 13
Form 4
+34.58%
6.47K
$60.67
-$2,372,416.66
25.17K
Scheduled
Nov 22
Form 4
+18.78%
2.96K
$118.68
-$280,322.16
18.7K
Mar 28
Form 4
-19.54%
-3.83K
—
—
15.75K
Feb 28 - Mar 4
Form 4
-30.28%
-8.50K
$80.83
-$3,734,609.22
19.57K
Scheduled
Feb 1
Form 4
-19.50%
-6.80K
$121.02
-$822,936.00
28.07K
Aug 8
Form 4
—
0
$75.16
-$6,130,308.88
34.87K
Scheduled
Jul 16
Form 4
+12.06%
3.75K
$89.22
-$139,718.52
34.87K
May 22
Form 4
+6.21%
1.82K
$51.69
$152.33
31.12K
Mar 15
Form 4
—
0
—
—
0
Mar 5
Form 4
+25.74%
6K
$37.88
-$175,838.96
29.3K
Aug 3
Form 4
+4.48%
1K
$27.49
-$661,685.36
23.3K
Scheduled
Jul 20 - Jul 21
Form 4
-0.68%
-152.00
$30.30
-$4,605.60
22.3K
Mar 19
Form 4
—
0
—
—
0
Mar 10
Form 4
+4.66%
1K
$23.85
$23,850.00
22.45K
Nov 9
Form 4
—
0
$36.95
-$322,700.00
21.45K
Scheduled
Sep 22
Form 4
+577.18%
18.29K
$31.95
-$354,000.00
21.45K
Scheduled
Sep 19
Form 4
-22.09%
-898.00
$26.07
-$23,410.86
3.17K
Aug 31
Form 4
+211.81%
2.76K
—
—
4.07K
Feb 29
Form 4/A
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Solid Biosciences Inc. (SLDB) Snapshot price: $7.19

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 13
Form 4
∞
7.68K
$2.78
-$14,920.26
7.68K
Dec 2 - Dec 4
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found